Trial site
Mary Mediatrix Medical Center
- 10running trials
- 5closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Lupus (SLE)7 trials
- COPD2 trials
- Ankylosing spondylitis1 trial
- Atrial fibrillation1 trial
- Coronary artery disease1 trial
- High blood pressure1 trial
- Stroke1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 310 trials
- Phase 24 trials
- Phase 2/31 trial
- Status
- Active, not recruiting8 trials
- Completed3 trials
- Terminated2 trials
- Enrolling by invitation1 trial
- Recruiting1 trial
- Lead sponsor
- Biogen3 trials
- Hoffmann-La Roche3 trials
- Janssen Research & Development, LLC3 trials
- Alfasigma S.p.A.1 trial
- Amgen1 trial
- and 4 more
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis
Active, not recruiting
Active, not recruiting
The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)
Active, not recruiting
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- High blood pressure1 recruiting
- Lupus (SLE)1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Terminated
A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)
Terminated
Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN)
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Completed
The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)
Site data: ClinicalTrials.govUpdated 19 Nov 2026